Amol S. Rangnekar

811 total citations
28 papers, 273 citations indexed

About

Amol S. Rangnekar is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Amol S. Rangnekar has authored 28 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 14 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Amol S. Rangnekar's work include Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (10 papers) and Hepatitis C virus research (5 papers). Amol S. Rangnekar is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (10 papers) and Hepatitis C virus research (5 papers). Amol S. Rangnekar collaborates with scholars based in United States, Ethiopia and Germany. Amol S. Rangnekar's co-authors include Robert J. Fontana, Frank Lammert, Richard M. Green, Brendan M. McGuire, Caitlyn Ellerbe, William M. Lee, Valerie Durkalski, Brett Sadowski, Valerie Durkalski and Iris Liou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Amol S. Rangnekar

23 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amol S. Rangnekar United States 10 168 143 80 56 23 28 273
Alexandra Shingina United States 11 174 1.0× 139 1.0× 145 1.8× 30 0.5× 27 1.2× 32 356
Dinesh Rawat India 11 149 0.9× 118 0.8× 131 1.6× 37 0.7× 14 0.6× 29 294
Aniruddha Phadke India 11 74 0.4× 157 1.1× 167 2.1× 49 0.9× 26 1.1× 25 347
Maha Elsabaawy Egypt 11 134 0.8× 167 1.2× 64 0.8× 29 0.5× 26 1.1× 60 292
Alessandra Pohlmann Germany 11 360 2.1× 349 2.4× 128 1.6× 28 0.5× 54 2.3× 17 494
Emrah Otan Türkiye 8 127 0.8× 76 0.5× 202 2.5× 16 0.3× 19 0.8× 26 317
Robert Tidswell United Kingdom 8 105 0.6× 111 0.8× 54 0.7× 29 0.5× 44 1.9× 10 250
Carlos Míguez Argentina 8 254 1.5× 219 1.5× 107 1.3× 31 0.6× 23 1.0× 11 321
Matthias Loehr Germany 7 282 1.7× 174 1.2× 189 2.4× 75 1.3× 33 1.4× 10 402

Countries citing papers authored by Amol S. Rangnekar

Since Specialization
Citations

This map shows the geographic impact of Amol S. Rangnekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amol S. Rangnekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amol S. Rangnekar more than expected).

Fields of papers citing papers by Amol S. Rangnekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amol S. Rangnekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amol S. Rangnekar. The network helps show where Amol S. Rangnekar may publish in the future.

Co-authorship network of co-authors of Amol S. Rangnekar

This figure shows the co-authorship network connecting the top 25 collaborators of Amol S. Rangnekar. A scholar is included among the top collaborators of Amol S. Rangnekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amol S. Rangnekar. Amol S. Rangnekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Kali, Christopher K. Wong, Amol S. Rangnekar, et al.. (2025). Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign‐Born: The FOCUS‐HBV Multicentre Cohort. Alimentary Pharmacology & Therapeutics. 61(12). 1913–1922.
2.
Singh, Harjit, et al.. (2024). S4621 Rare Hepatic Manifestation in Influenza A H1N1: A Case Report of Acute Liver Failure. The American Journal of Gastroenterology. 119(10S). S2930–S2931.
3.
Woo, Stephanie, et al.. (2023). COVID-19-Associated Liver Injury. PubMed. Volume 15. 1–9. 2 indexed citations
4.
Singh, Harjit, et al.. (2023). Hemorrhagic Shock from a Duodenal Ulcer Eroding into an Ectopic Varix. SHILAP Revista de lepidopterología. 2023. 1–3. 1 indexed citations
5.
Woo, Stephanie, et al.. (2022). Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma. Current Oncology. 29(12). 9813–9825. 13 indexed citations
6.
Rangnekar, Amol S., et al.. (2022). S2593 Hemorrhagic Shock From a Duodenal Ulcer Eroding Into an Ectopic Varix. The American Journal of Gastroenterology. 117(10S). e1720–e1721. 1 indexed citations
7.
Nguyen, Veronica, et al.. (2022). S3235 Staphylococcus Aureus Endocarditis Complicated by Endophthalmitis in a Young Patient with Cirrhosis. The American Journal of Gastroenterology. 117(10S). e2064–e2064.
8.
Sadowski, Brett, et al.. (2021). PRO: Cardiac Catheterization Is the Optimal Strategy for Cardiovascular Risk Stratification in This Patient. Clinical Liver Disease. 17(1). 33–36. 1 indexed citations
9.
Rangnekar, Amol S., et al.. (2020). S2664 Acute HEV Infection Causing Elevated Liver Enzymes in a Kidney Transplant Recipient. The American Journal of Gastroenterology. 115(1). S1396–S1396.
10.
Poto, Cristina Di, Rency S. Varghese, Yi Zhao, et al.. (2018). Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection. PLoS ONE. 13(3). e0192748–e0192748. 18 indexed citations
11.
Rangnekar, Amol S., et al.. (2017). Multi-Drug-resistant Organism (MDRO) Infections in Liver Transplant Recipients 30 Days Post-Transplant. Open Forum Infectious Diseases. 4(suppl_1). S709–S709. 1 indexed citations
12.
Levine, Irving, Amol S. Rangnekar, & Aaron Tokayer. (2017). Low frequency of polyps in colonic regions with diverticulosis. International Journal of Colorectal Disease. 32(11). 1597–1602. 7 indexed citations
13.
Osborne, Nicholas H., et al.. (2016). The Effect of Hospital Characteristics on Racial/Ethnic Variation in Cirrhosis Mortality. Journal of Racial and Ethnic Health Disparities. 4(2). 243–251. 9 indexed citations
14.
Rangnekar, Amol S. & Robert J. Fontana. (2013). IL‐28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta‐analysis. Journal of Viral Hepatitis. 20(6). 377–384. 16 indexed citations
15.
Rangnekar, Amol S., Caitlyn Ellerbe, Valerie Durkalski, et al.. (2013). Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. Liver Transplantation. 19(9). 991–1000. 23 indexed citations
16.
Rangnekar, Amol S. & Robert J. Fontana. (2012). Meta‐analysis: IL ‐28 B genotype and sustained viral clearance in HCV genotype 1 patients. Alimentary Pharmacology & Therapeutics. 36(2). 104–114. 34 indexed citations
17.
Rangnekar, Amol S. & Robert J. Fontana. (2012). Managing drug-drug interactions with boceprevir and telaprevir. Clinical Liver Disease. 1(2). 36–40. 5 indexed citations
18.
Elmunzer, B. Joseph, Amol S. Rangnekar, Sameer D. Saini, et al.. (2011). Endoscopic Findings and Clinical Outcomes in Ventricular Assist Device Recipients with Gastrointestinal Bleeding. Digestive Diseases and Sciences. 56(11). 3241–3246. 24 indexed citations
19.
Rangnekar, Amol S., Daniel M. Morgan, Paul Knechtges, et al.. (2008). M1806 Complaints Suggestive of Irritable Bowel Syndrome Are Common in Patients with Puborectalis Dyssynergia: An Under-Recognized Overlap Syndrome. Gastroenterology. 134(4). A–423. 3 indexed citations
20.
Rangnekar, Amol S., et al.. (2006). Quantitative trait loci analysis of mice administered the methionine–choline deficient dietary model of experimental steatohepatitis. Liver International. 26(8). 1000–1005. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra Shingina Breakdown of academic impact, for papers by Dinesh Rawat Breakdown of academic impact, for papers by Aniruddha Phadke Breakdown of academic impact, for papers by Maha Elsabaawy Breakdown of academic impact, for papers by Alessandra Pohlmann Breakdown of academic impact, for papers by Emrah Otan Breakdown of academic impact, for papers by Robert Tidswell Breakdown of academic impact, for papers by Carlos Míguez Breakdown of academic impact, for papers by Matthias Loehr
Rankless by CCL
2026